Skip to main content
Journal cover image

Survival is not the only valuable end point in melanoma screening.

Publication ,  Journal Article
Curiel-Lewandrowski, C; Kim, CC; Swetter, SM; Chen, SC; Halpern, AC; Kirkwood, JM; Leachman, SA; Marghoob, AA; Ming, ME; Grichnik, JM ...
Published in: J Invest Dermatol
May 2012

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Invest Dermatol

DOI

EISSN

1523-1747

Publication Date

May 2012

Volume

132

Issue

5

Start / End Page

1332 / 1337

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Secondary Prevention
  • Primary Prevention
  • Melanoma
  • Humans
  • Health Education
  • False Positive Reactions
  • Early Detection of Cancer
  • Dermatology & Venereal Diseases
  • Cost-Benefit Analysis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Curiel-Lewandrowski, C., Kim, C. C., Swetter, S. M., Chen, S. C., Halpern, A. C., Kirkwood, J. M., … Melanoma Prevention Working Group—Pigmented Skin Lesion Sub-Committee, . (2012). Survival is not the only valuable end point in melanoma screening. J Invest Dermatol, 132(5), 1332–1337. https://doi.org/10.1038/jid.2012.3
Curiel-Lewandrowski, Clara, Caroline C. Kim, Susan M. Swetter, Suephy C. Chen, Allan C. Halpern, John M. Kirkwood, Sancy A. Leachman, et al. “Survival is not the only valuable end point in melanoma screening.J Invest Dermatol 132, no. 5 (May 2012): 1332–37. https://doi.org/10.1038/jid.2012.3.
Curiel-Lewandrowski C, Kim CC, Swetter SM, Chen SC, Halpern AC, Kirkwood JM, et al. Survival is not the only valuable end point in melanoma screening. J Invest Dermatol. 2012 May;132(5):1332–7.
Curiel-Lewandrowski, Clara, et al. “Survival is not the only valuable end point in melanoma screening.J Invest Dermatol, vol. 132, no. 5, May 2012, pp. 1332–37. Pubmed, doi:10.1038/jid.2012.3.
Curiel-Lewandrowski C, Kim CC, Swetter SM, Chen SC, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Grichnik JM, Melanoma Prevention Working Group—Pigmented Skin Lesion Sub-Committee. Survival is not the only valuable end point in melanoma screening. J Invest Dermatol. 2012 May;132(5):1332–1337.
Journal cover image

Published In

J Invest Dermatol

DOI

EISSN

1523-1747

Publication Date

May 2012

Volume

132

Issue

5

Start / End Page

1332 / 1337

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Secondary Prevention
  • Primary Prevention
  • Melanoma
  • Humans
  • Health Education
  • False Positive Reactions
  • Early Detection of Cancer
  • Dermatology & Venereal Diseases
  • Cost-Benefit Analysis